KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Common Equity: 2009-2024

Historic Common Equity for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $596.8 million.

  • Dynavax Technologies' Common Equity fell 21.61% to $534.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.1 million, marking a year-over-year decrease of 21.61%. This contributed to the annual value of $596.8 million for FY2024, which is 4.06% down from last year.
  • Latest data reveals that Dynavax Technologies reported Common Equity of $596.8 million as of FY2024, which was down 4.06% from $622.1 million recorded in FY2023.
  • Dynavax Technologies' Common Equity's 5-year high stood at $622.1 million during FY2023, with a 5-year trough of $58.7 million in FY2020.
  • Moreover, its 3-year median value for Common Equity was $596.8 million (2024), whereas its average is $600.0 million.
  • As far as peak fluctuations go, Dynavax Technologies' Common Equity skyrocketed by 608.00% in 2020, and later dropped by 4.06% in 2024.
  • Yearly analysis of 5 years shows Dynavax Technologies' Common Equity stood at $58.7 million in 2020, then surged by 278.88% to $222.4 million in 2021, then skyrocketed by 161.28% to $581.0 million in 2022, then rose by 7.07% to $622.1 million in 2023, then fell by 4.06% to $596.8 million in 2024.